Numerous studies have demonstrated that WT1 plays an oncogenic role in various solid cancers including breast cancer, by promoting epithelial-to-mesenchymal transition and lowering chemotherapy efficacy (35, 36). This evidence concerns the gene WT1 and breast carcinoma.